Click Here |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: June 2023
Volume 8 | Issue 6
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 8
Issue Published : 85
Article Submitted : 7835
Article Published : 4002
Total Authors : 10443
Total Reviewer : 547
Total Countries : 81
Indexing Partner
Licence
Published Paper Details
|
|
Paper Title: | NEW METHOD DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR THE DETERMINATION OF LEVOMILNACIPRAN IN BULK AND PHARMACEUTICAL DOSAGE FORM. |
Authors Name: | KUMARI KHUSHBOO , Chandanam Sreedhar , Sreenivas Rao T , Harsha K Triphathy , Dillan Kumar |
Download E-Certificate: | Download |
Author Reg. ID: |
IJRTI_184478
|
Published Paper Id: | IJRTI2210101 |
Published In: | Volume 7 Issue 10, October-2022 |
DOI: | |
Abstract: | To establish sensitive and accurate methods for developing and validating analytical methods for estimation of levomilnacipran in bulk and pharmaceutical dosage forms. A mixture of 10 mM Dipotassium hydrogen phosphate buffer pH 6.5 and Methanol in the ratio of 50:50 (v/v%) was used as the mobile phase. A working standard solution of a concentration of 20 µg/ml was used. An XBridge™ C18 column 5µ (250 mm x 4.6 mm) was used for the analysis at a flow rate of 1 ml/min, injection volume of 20 µl, run time of 10 mins, and detection wavelength of 210 nm. The %RSD values of precision studies were found to be below the accepted limit of 2%. The method was found to be linear with a correlation coefficient (r2) of 0.998. The method was also found to be accurate and robust with suitable values. The LOD and LOQ of the method were found to be 1.42 µg/ml and 4.75 µg/ml respectively. |
Keywords: | levomilnacipran, RP-HPLC, validation, LOD, LOQ |
Cite Article: | "NEW METHOD DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR THE DETERMINATION OF LEVOMILNACIPRAN IN BULK AND PHARMACEUTICAL DOSAGE FORM.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 10, page no.747 - 753, October-2022, Available :http://www.ijrti.org/papers/IJRTI2210101.pdf |
Downloads: | 000202437 |
ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
Publication Details: |
Published Paper ID: IJRTI2210101
Registration ID:184478
Published In: Volume 7 Issue 10, October-2022
DOI (Digital Object Identifier):
Page No: 747 - 753 Country: Bangalore, karnataka, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2210101 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2210101 |
Share Article: | |
Click Here to Download This Article |
|
Article Preview | |
|
Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
![]() |
![]() |
![]() |
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
![]() Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
Important Details
Social Media
Indexing Partner |
|||
Copyright © 2023 - All Rights Reserved - IJRTI |
Facebook Twitter Instagram LinkedIn